{
  "thread": {
    "uuid": "a9e98e2b19a4722eda6d976ab1974d874a9b9fae",
    "url": "https://www.keysnews.com/lifestyles/health/fda-approves-qfitlia-to-cut-bleeding-episodes-in-patients-with-hemophilia/image_2fb909b5-8012-528f-8119-61c434fbd7e6.html",
    "site_full": "www.keysnews.com",
    "site": "keysnews.com",
    "site_section": "http://www.keysnews.com/search/?f=rss&amp;t=article&amp;l=50&amp;s=start_time&amp;sd=desc&amp;k%5b%5d=%23topstory",
    "site_categories": [
      "religion",
      "media"
    ],
    "section_title": "www.keysnews.com - RSS Results",
    "site_title": "keysnews.com",
    "title": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
    "title_full": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
    "published": "2025-04-03T01:07:00.000+03:00",
    "replies_count": 0,
    "participants_count": 0,
    "site_type": "news",
    "country": "US",
    "main_image": "https://bloximages.newyork1.vip.townnews.com/keysnews.com/content/tncms/assets/v3/editorial/2/fb/2fb909b5-8012-528f-8119-61c434fbd7e6/67edb79522837.image.jpg?crop=1200%2C630%2C0%2C85",
    "performance_score": 0,
    "domain_rank": 63275,
    "domain_rank_updated": "2025-04-01T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "a9e98e2b19a4722eda6d976ab1974d874a9b9fae",
  "url": "https://www.keysnews.com/lifestyles/health/fda-approves-qfitlia-to-cut-bleeding-episodes-in-patients-with-hemophilia/image_2fb909b5-8012-528f-8119-61c434fbd7e6.html",
  "ord_in_thread": 0,
  "author": null,
  "published": "2025-04-03T01:07:00.000+03:00",
  "title": "FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia",
  "text": "As featured on\nWEDNESDAY, April 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology",
    "Human Interest"
  ],
  "topics": [
    "Health->health treatment and procedure",
    "Health->drug rehabilitation",
    "Science and Technology->medical research",
    "Science and Technology->biomedical science"
  ],
  "ai_allow": false,
  "has_canonical": false,
  "breaking": false,
  "webz_reporter": false,
  "external_links": [],
  "entities": {
    "persons": [
      {
        "name": "Qfitlia",
        "sentiment": "neutral"
      }
    ],
    "locations": [],
    "organizations": [
      {
        "name": "HealthDay News",
        "sentiment": "neutral",
        "tickers": []
      },
      {
        "name": "The U.S. Food and Drug Administration",
        "sentiment": "neutral",
        "tickers": []
      },
      {
        "name": "IX",
        "sentiment": "neutral",
        "tickers": []
      }
    ]
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-04-03T01:29:16.251+03:00",
  "updated": "2025-04-03T01:29:16.251+03:00"
}